Abilify Drug Overview
Links shared publicly online about this topic
Abilify (Aripiprazole)
dynamicchiropractic.com — “Author: Daniel Hough. Title: Abilify (Aripiprazole). Summary: Abilify is currently being marketed heavily as a drug to add to antidepressants already being taken.” View full resource at dynamicchiropractic.com
Most Recently Shared on March 4, 2010 at 12:29 am By:
Dr. Gabe Spruch Chiropractor, Acupuncturist, Doctor, and CAM
Abilify (Aripiprazole): http://www.dynamicchiropractic.com/mpacms/dc/article.php?t=14&id=54392 via @addthis
Abilify Treats Autism-Related Irritability
webmd.com — “The drug abilify (aripiprazole) may help ease the symptoms of irritability related to autism in children and adolescents, a study shows.” View full resource at webmd.com
Most Recently Shared on November 30, 2009 at 8:08 pm By:
webMD: Abilify Treats Autism-Related Irritability http://bit.ly/6ylRJR Full http://bit.ly/5EFNtO
Bipolar-disorder Related Drugs, Abilify, Quetiapine - Drugs - EverydayHealth.com
everydayhealth.com — “Find information on prescription and OTC drugs that treat Bipolar-disorder like Abilify, Abilify Discmelt, Aripiprazole, Calan, Calan SR, Carbamazepine, Carbatrol, Catapres, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3. Find medical information on side effects, drug interactions, dosage, and user ratings and reviews.” View full resource at everydayhealth.com
Most Recently Shared on April 8, 2010 at 3:09 am By:
Peter H Brown Doctor and Psychologist
Bipolar-disorder Related Drugs, Abilify, Quetiapine ... http://bit.ly/b62GaM #bipolar
Quebec agrees reimbursement of ABILIFY for schizophrenia treatment in public drug plans
news-medical.net — “Bristol-Myers Squibb Canada is pleased to announce that Quebec has recognized the value of ABILIFY (aripiprazole) for the treatment of schizophrenia and related psychotic disorders in adults and has agreed to list ABILIFY as a reimbursed full benefit on the Quebec public drug plans as of October 14, 2010.” View full resource at news-medical.net
Most Recently Shared on October 27, 2010 at 8:46 am By:
Quebec agrees reimbursement of ABILIFY for schizophrenia treatment in public drug plans: Bristol-Myers Squibb Cana... http://bit.ly/bY3JVo
FDA approves sNDA for pediatric autism drug ABILIFY
news-medical.net — “Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ABILIFY® (aripiprazole) for the treatment of irritability associated with autistic disorder in pediatric patients ages 6 to 17 years, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.” View full resource at news-medical.net
Most Recently Shared on November 21, 2009 at 9:29 am By:
Obesity News: FDA approves sNDA for pediatric autism drug ABILIFY: Bristol-Myers Squibb Company an.. http://twurl.nl/kl8lfe
U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated With Autistic Disorder In Patients
medicalnewstoday.com — “(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Appl” View full resource at medicalnewstoday.com
Most Recently Shared on November 28, 2009 at 11:28 am By:
MNT Clinical Trials Health News
U.S. Food And Drug Administration Approves ABILIFY® (aripiprazole) For The Treatment Of Irritability Associated.. http://bit.ly/51H21G
U.S. Food and Drug Administration Approves Abilify (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)
drugs.com — “Abilify (aripiprazole) is used to treat irritability associated with autistic disorder in pediatric patients. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 24, 2009 at 12:10 am By:
FDA Approves Abilify for Irritability Associated with Autistic Disorder in Pediatric Patients - http://bit.ly/62jJ8P
How Abilify Works, And Why It Matters « Thought Broadcast
thoughtbroadcast.com — “How Abilify Works, And Why It Matters « Thought Broadcast” View full resource at thoughtbroadcast.com
Most Recently Shared on September 13, 2011 at 10:32 pm By:
Michael Lara, MD Doctor, Psychiatrist, and Physician
How can one drug do so much? Maybe because we don't know enough about how it really works, or about what really... http://t.co/6u3t85a
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Drugs and Devices OW OW Health
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
Bristol-Myers Extends Abilify Sales Pact - WSJ.com
feeds.wsjonline.com — “Bristol-Myers Squibb will sell the psychiatric drug Abilify into 2015 under a deal with Otsuka Pharmaceutical.” View full resource at feeds.wsjonline.com
Most Recently Shared on April 6, 2009 at 2:23 pm By:
Bristol-Meyers, Otsuka Extend Deal http://tinyurl.com/dk2hvu
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripiprazole), Europe
medicalnewstoday.com — “The european medicines agency has been formally notified by otsuka pharmaceutical europe ltd of its decision to withdraw its application for an extension of indication for the centrally authorised” View full resource at medicalnewstoday.com
Most Recently Shared on November 20, 2009 at 11:41 am By:
Otsuka Pharmaceutical Europe Ltd Withdraws Its Application For An Extension Of Indication For Abilify (aripipra.. http://bit.ly/1QCH4R
NICE wants more data on BMS schizophrenia drug Abilify for teens | Reuters - Jack's posterous
pharmagossip.posterous.com — “NICE wants more data on BMS schizophrenia drug Abilify for teens | Reuters - Jack's posterous” View full resource at pharmagossip.posterous.com
Most Recently Shared on September 10, 2010 at 5:48 am By:
Jack Friday - PharmaGossip Health Blog
NICE wants more data on BMS schizophrenia drug Abilify for teens | Reuters http://post.ly/wfOV
Bipolar Treatment Abilify Questioned For Long-Term Use | ThirdAge
thirdage.com — “The bipolar treatment drug Abilify could potentially be keeping doctors from prescribing more established drugs, a new review suggests.” View full resource at thirdage.com
Most Recently Shared on May 5, 2011 at 9:23 pm By:
Peter H Brown Doctor and Psychologist
Bipolar Treatment Abilify Questioned For Long-Term Use http://bit.ly/kFnxeu #bipolar
News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health
reuters.com — “News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health” View full resource at reuters.com
Most Recently Shared on September 10, 2010 at 3:45 am By:
Hisham Rana, MD Doctor and Physician
News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health
FDA panel recommends change to label of Abilify - Related Stories - AAP SmartBrief
smartbrief.com — “An FDA panel unanimously concluded that the label of Bristol-Myers Squibb's antipsychotic Abilify for use in children lacks information on the risk of excessive weight gain. The panel advised Bristol-Myers to keep monitoring pediatric use of the drug and move data on its metabolic effect on children” View full resource at smartbrief.com
Most Recently Shared on December 11, 2009 at 6:07 am By:
Clara Song Doctor, Pediatrician, and Physician
FDA panel recommends change to label of Abilify http://sbne.ws/r/3qaF
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Dr. Gabe Spruch
I am a chiropractic physician and licensed professional acupuncturist practicing in Jeffersonville Indiana
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
Advertisement
